1,718
Views
1
CrossRef citations to date
0
Altmetric
Editorial

Delivering Pharmacogenetic Testing to the Masses: An Achievable Goal?

References

  • Collins F . Has the revolution arrived? Nature464(7289) , 674–675 (2010).
  • Nebert DW . Given the complexity of the human genome, can ‚personalised medicine‘ or ‚individualised drug therapy‘ ever be achieved? Hum. Genomics3(4) , 299–300 (2009).
  • Shah RR , ShahDR. Personalized medicine: is it a pharmacogenetic mirage? Br. J. Clin. Pharmacol.74(4) , 698–721 (2012).
  • Scott SA . Personalizing medicine with clinical pharmacogenetics. Genet. Med.13(12) , 987–995 (2011).
  • Chai G , GovernaleL, McMahonAW, TrinidadJP, StaffaJ, MurphyD. Trends of outpatient prescription drug utilization in US children, 2002–2010. Pediatrics130(1) , 23–31 (2012).
  • Cox ER , HalloranDR, HomanSM, WelliverS, MagerDE. Trends in the prevalence of chronic medication use in children: 2002–2005. Pediatrics122(5) , e1053–e1061 (2008).
  • Stange KC , FlockeSA, GoodwinMA. Opportunistic preventive services delivery. Are time limitations and patient satisfaction barriers? J. Fam. Pract.46(5) , 419–424 (1998).
  • Yarnall KS , PollakKI, OstbyeT, KrauseKM, MichenerJL. Primary care: is there enough time for prevention? Am. J. Public Health93(4) , 635–641 (2003).
  • Smith M , BatesDW, BodenheimerT, ClearyPD. Why pharmacists belong in the medical home. Health Aff. (Millwood)29(5) , 906–913 (2010).
  • Anderson DR , WhitmerRW, GoetzelRZ et al. The relationship between modifiable health risks and group-level health care expenditures. Health Enhancement Research Organization (HERO) Research Committee. Am. J. Health Promot. 15(1) , 45–52 (2000).
  • Baicker K , CutlerD, SongZ. Workplace wellness programs can generate savings. Health Aff. (Millwood)29(2) , 304–311 (2010).
  • Osilla KC , van Busum K, Schnyer C, Larkin JW, Eibner C, Mattke S. Systematic review of the impact of worksite wellness programs. Am. J. Manag. Care18(2) , e68–e81 (2012).
  • Haga SB , LapointeNM. The potential impact of pharmacogenetic testing on medication adherence. Pharmacogenomics J. doi:10.1038/tpj.2013.33 (2013) (Epub ahead of print).
  • Mehrotra A , LaveJR. Visits to retail clinics grew fourfold from 2007 to 2009, although their share of overall outpatient visits remains low. Health Aff. (Millwood)31(9) , 2123–2129 (2012).
  • Rudavsky R , PollackCE, MehrotraA. The geographic distribution, ownership, prices, and scope of practice at retail clinics. Ann. Intern. Med.151(5) , 315–320 (2009).
  • Uscher-Pines L , HarrisKM, BurnsRM, MehrotraA. The growth of retail clinics in vaccination delivery in the U.S. Am. J. Prev. Med.43(1) , 63–66 (2012).
  • Mehrotra A , LiuH, AdamsJL et al. Comparing costs and quality of care at retail clinics with that of other medical settings for 3 common illnesses. Ann. Intern. Med. 151(5) , 321–328 (2009).
  • Reid RO , AshwoodJS, FriedbergMW, WeberES, SetodjiCM, MehrotraA. Retail clinic visits and receipt of primary care. J. Gen. Intern. Med.28(4) , 504–512 (2013).
  • Nkansah N , MostovetskyO, YuC et al. Effect of outpatient pharmacists‘ non-dispensing roles on patient outcomes and prescribing patterns. Cochrane Database Syst. Rev. 7 , CD000336 (2010).
  • Taitel M , CohenE, DuncanI, PegusC. Pharmacists as providers: targeting pneumococcal vaccinations to high risk populations. Vaccine29(45) , 8073–8076 (2011).
  • Deshpande M , SchauerJ, MottDA, YoungHN, CoryP. Parents‘ perceptions of pharmacists as providers of influenza vaccine to children. J. Am. Pharm. Assoc.53(5) , 488–495 (2013).
  • Costanza ME , LuckmannR, StoddardAM et al. Using tailored telephone counseling to accelerate the adoption of colorectal cancer screening. Cancer Detect. Prev. 31(3) , 191–198 (2007).
  • Burmester JK , SedovaM, ShaperoMH, MansfieldE. DMET microarray technology for pharmacogenomics-based personalized medicine. Methods Mol. Biol.632 , 99–124 (2010).
  • Johnson JA , BurkleyBM, LangaeeTY, Clare-SalzlerMJ, KleinTE, AltmanRB. Implementing personalized medicine: development of a cost-effective customized pharmacogenetics genotyping array. Clin. Pharmacol. Ther.92(4) , 437–439 (2012).
  • Patel CJ , SivadasA, TabassumR et al. Whole genome sequencing in support of wellness and health maintenance. Genome Med. 5(6) , 58 (2013).
  • Green RC , BergJS, GrodyWW et al. ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing. Genet. Med. 15(7) , 565–574 (2013).
  • Ashley EA , ButteAJ, WheelerMT et al. Clinical assessment incorporating a personal genome. Lancet 375(9725) , 1525–1535 (2010).
  • Haga SB , O‘DanielJM, TindallGM, LipkusIR, AgansR. Survey of US public attitudes toward pharmacogenetic testing. Pharmacogenomics J.12(3) , 197–204 (2012).

▪ Websites

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.